Source comparison
Best CJC-1295 no DAC & Ipamorelin Dosage Sleep 2026: Protocol Comparison
This table compares the three most common CJC-1295 no DAC & Ipamorelin sleep protocols used in research settings as of 2026, including dosage ranges, timing windows, administration frequency, and observed outcomes. Standard Sleep Protocol 100–200mcg 30–45 min
This comparison does not assign a generated winner or score.
- This table compares the three most common CJC-1295 no DAC & Ipamorelin sleep protocols used in research settings as of 2026, including dosage ranges, timing windows, administration frequency, and observed outcomes.
- Standard Sleep Protocol
- 100–200mcg
- 30–45 min pre-sleep
- 5 days/week
- 18–22% increase in slow-wave sleep, 12-min reduced sleep latency
- Optimal for sustained sleep architecture improvement without receptor desensitisation
- High-Dose Protocol
- 250–300mcg
- Minimal additional benefit; 40% incidence of cortisol elevation
- Not recommended. Exceeds efficacy ceiling and increases side effect risk
- Daily Low-Dose Protocol
- 50–100mcg
- 7 days/week
- 8–12% increase in slow-wave sleep; effect diminishes after 6–8 weeks
- Sub-therapeutic for most; daily dosing accelerates receptor downregulation